InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
11
T+90 hit rate
75%
T+90 mean return
+6.7%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Tatsis Ourania, Vice-Président Exécutif. Officer active across 1 company, notably Vertex Pharmaceuticals INC / MA. Cumulatively, 30 filings have been published. Split: 0 buy · 11 sells. Total volume traded: €9.4m. Activity tracked since 1 February 2022. The latest transaction was disclosed on 2 July 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations30 total
▼
1,500 shares@ US$524.99Common StockSEC:0000875320-26-000245:0
3,242 shares@ US$499.996.6% of flowCommon StockSEC:0000875320-25-000146:0
4,058 shares@ US$485.498.3% of flowCommon StockSEC:0000875320-25-000141:0
4,962 shares@ US$479.6110.0% of flowCommon StockSEC:0000875320-25-000135:0
3,310 shares@ US$483.286.8% of flowCommon StockSEC:0000875320-25-000115:0
2,293 shares@ US$463.464.5% of flowCommon StockSEC:0000875320-25-000095:0
6,211 shares0Common StockSEC:0000875320-25-000073:0
2,143 shares@ US$467.984.3% of flowCommon StockSEC:0000875320-25-000048:0
10,262 shares0Common StockSEC:0000875320-25-000024:0
2,175 shares@ US$460.004.1% of flowCommon StockSEC:0000875320-24-000168:0
2,350 shares@ US$439.114.2% of flowCommon StockSEC:0000875320-24-000166:0
3,309 shares@ US$431.795.8% of flowCommon StockSEC:0000875320-24-000109:0
▼
360 shares@ US$421.770.6% of flowCommon StockSEC:0000875320-24-000093:0
4,499 shares@ US$424.017.8% of flowCommon StockSEC:0000875320-24-000080:0
●
2,100 shares@ US$422.743.6% of flowCommon StockSEC:0000875320-24-000055:0
6,976 shares0Common StockSEC:0000875320-24-000032:0
▼
2,500 shares@ US$355.003.6% of flowCommon StockSEC:0001209191-23-047309:0
5,750 shares@ US$345.798.0% of flowCommon StockSEC:0000899243-23-018112:0
●
3,308 shares@ US$289.124.0% of flowCommon StockSEC:0001209191-23-013765:0
4,498 shares@ US$292.855.5% of flowCommon StockSEC:0001209191-23-011704:0
▼
71 shares@ US$295.890.1% of flowCommon StockSEC:0001209191-23-010061:0
●
1,377 shares@ US$294.331.7% of flowCommon StockSEC:0001209191-23-009237:0
6,194 shares0Common StockSEC:0001209191-23-006996:0
▼
292 shares@ US$297.540.4% of flowCommon StockSEC:0000899243-22-028248:0
▼
2,799 shares@ US$250.100.0006% mcap28.2% of flowCommon StockSEC:0000899243-22-011705:0
25 of 30 declarations
About Tatsis Ourania
Tatsis Ourania is Executive Vice President and Chief Regulatory & Quality Officer at VERTEX PHARMACEUTICALS INC / MA. In this role, she oversees regulatory compliance and quality initiatives, ensuring that the company meets industry standards.
